🇺🇸 FDA
Patent

US 9969804

Methods and compositions for treating and preventing disease associated with alpha-V beta-8 integrin

granted A61PA61P11/00A61P37/00

Quick answer

US patent 9969804 (Methods and compositions for treating and preventing disease associated with alpha-V beta-8 integrin) held by The Regents of the University of California expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P11/00, A61P37/00